Morgan Stanley upgraded UnitedHealth Group to Buy and raised its price target to $450 on June 6, 2026.

The entities involved

• UnitedHealth Group →

  for-profit health care company

  • United Therapeutics filed Form 13F with the Securities and Exchange Commission.Mon 11:42
  • The White House threatened new tariffs on Canadian imports, highlighting the healthcare sector's reliance on integrated Canadian supply chains.Sun 07:20
• Morgan Stanley →

  U.S. investment bank

  • Financial firms including Morgan Stanley, Truist Financial, Jefferies Financial Group, and CIBC issued rating and price objective updates for Clearway Energy.Mon 17:33
  • Goldman Sachs, Morgan Stanley, JPMorgan Chase, and Bank of America are competing in the global investment banking sector.Mon 17:24

Related events

• Financial firms including Bank of America, Morgan Stanley, and Truist Financial adjusted price targets and ratings for Somnigroup International Inc.Aug 7
• Morgan Stanley raised its price target and maintained an overweight rating for Wingstop.Jun 8
• Barclays analyst upgraded a managed care company's target price to $515, noting both Humana and UnitedHealth Group operate in the sector.Fri 20:34
• TD Cowen, Morgan Stanley, Cantor Fitzgerald, Benchmark, and other firms adjusted price targets for Snowflake Inc. on August 31, 2026.Sep 1
• Morgan Stanley lowered its price target to $13.00 and set an 'underweight' rating, while another firm increased its price objective to $19.00 and gave a 'buy' rating for Sally Beauty Holdings.Aug 30